Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13G (including amendments thereto) with respect to the shares of Common Stock, par value $0.00001 per share, of Virpax Pharmaceuticals, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement be included as Exhibit 1 to such Schedule 13G. In evidence thereof, the undersigned hereby execute this agreement this 14th day of February, 2022.
VIRPAX PHARMACEUTICALS, LLC | |||
By: | /s/ Anthony P. Mack | ||
Name: Anthony P. Mack | |||
Title: Managing Member | |||
/s/ Anthony P. Mack | |||
Anthony P. Mack | |||